...
首页> 外文期刊>The British journal of psychiatry : >Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas
【24h】

Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas

机译:基因组突变签名显示人B细胞淋巴瘤的明显发育路径

获取原文
获取原文并翻译 | 示例
           

摘要

Both somatic hypermutation (SHM) and class switch recombination (CSR) are initiated by activation-induced cytidine deaminase (AID). Dysregulation of these processes has been linked to B cell lymphomagenesis. Here we performed an in-depth analysis of diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) genomes. We characterized seven genomic mutational signatures, including two B cell tumor-specific signatures, one of which is novel and associated with aberrant SHM. We further identified two major mutational signatures (K1 and K2) of clustered mutations (kataegis) resulting from the activities of AID or error-prone DNA polymerase eta, respectively. K1 was associated with the immunoglobulin (Ig) switch region mutations/translocations and the ABC subtype of DLBCL, whereas K2 was related to the Ig variable region mutations and the GCB subtype of DLBCL and FL. Similar patterns were also observed in chronic lymphocytic leukemia subtypes. Thus, alterations associated with aberrant CSR and SHM activities can be linked to distinct developmental paths for different subtypes of B cell lymphomas.
机译:体细胞超突变(SHM)和类开关重组(CSR)都是由激活诱导的胞苷脱氨酶(AID)启动的。这些过程的失调与B细胞淋巴瘤有关。在这里,我们对弥漫性大B细胞淋巴瘤(DLBCL)和滤泡性淋巴瘤(FL)基因组进行了深入分析。我们鉴定了七个基因组突变特征,包括两个B细胞肿瘤特异性特征,其中一个是新的,与异常SHM相关。我们进一步确定了聚集突变(kataegis)的两个主要突变特征(K1和K2),分别由AID或易出错DNA聚合酶eta的活动引起。K1与免疫球蛋白(Ig)开关区突变/易位和DLBCL的ABC亚型相关,而K2与DLBCL和FL的Ig可变区突变和GCB亚型相关。在慢性淋巴细胞白血病亚型中也观察到类似的模式。因此,与异常CSR和SHM活动相关的改变可能与不同亚型B细胞淋巴瘤的不同发育路径有关。

著录项

  • 来源
  • 作者单位

    Tianjin Med Univ Canc Inst &

    Hosp Dept Lymphoma Natl Clin Res Ctr Canc Key Lab Canc Prevent &

    Tianjin Med Univ Canc Inst &

    Hosp Dept Lymphoma Natl Clin Res Ctr Canc Key Lab Canc Prevent &

    BGI Shenzhen Shenzhen Peoples R China;

    BGI Shenzhen Shenzhen Peoples R China;

    Tianjin Med Univ Canc Inst &

    Hosp Dept Lymphoma Natl Clin Res Ctr Canc Key Lab Canc Prevent &

    Tianjin Med Univ Canc Inst &

    Hosp Dept Lymphoma Natl Clin Res Ctr Canc Key Lab Canc Prevent &

    Chinese Acad Sci Ctr Excellence Mol Cell Sci Shanghai Inst Biochem &

    Cell Biol State Key Lab Mol;

    Shanghai Jiao Tong Univ Shanghai Inst Immunol Dept Immunol &

    Microbiol State Key Lab Oncogenes &

    BGI Shenzhen Shenzhen Peoples R China;

    BGI Shenzhen Shenzhen Peoples R China;

    NIAMSD Genom &

    Immun NIH Bethesda MD 20892 USA;

    Tianjin Med Univ Canc Inst &

    Hosp Dept Lymphoma Natl Clin Res Ctr Canc Key Lab Canc Prevent &

    BGI Shenzhen Shenzhen Peoples R China;

    Tianjin Med Univ Canc Inst &

    Hosp Dept Lymphoma Natl Clin Res Ctr Canc Key Lab Canc Prevent &

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 精神病学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号